Advanced Gastric Cancer | AG9801
A phase II study of irinotecan, leucovorin and 5-fluorouracil in advanced gastric cancer.
Schema
Summary
This trial was designed to assess the efficacy and toxicity of irinotecan, leucovorin, and 5-flourouracil for patients with advanced gastric cancer.
